Brain Diseases: Clinical Trials

1,622 trials for Brain Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

894 completed, 285 unknown, 139 recruiting, 134 terminated. 1622 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41622Completed 894, Unknown 285, Recruiting 139, Terminated 134, Not yet recruiting 76, Withdrawn 48, Active not recruiting 32, Enrolling by invitation 11, Suspended 3

Follow Brain Diseases: new trials by email Literature Review of Brain Diseases trials Research Report on Brain Diseases

Trials (filtered) newest first · largest first

All 1,622 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics
Levodopa (L-dopa) - Parkinson's Disease
Phase 4Not yet recruitingBeth Israel Deaconess Medical Center402027-07-012026-08-28
Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness
Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution, Placebo - Acute Mountain Sickness
Phase 4Not yet recruitingInsel Gruppe AG, University Hospital Bern302027-06-012026-07-01
Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH
Nortriptyline, Amitriptyline - Migraine
Phase 4Not yet recruitingSultan Qaboos University902027-05-012026-10-02
Migraine Menopause Study
Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution, Placebo Normal Saline (NS) - Migraine, Menopausal
Phase 4Not yet recruitingAlberta Neurologic Centre1202027-02-012026-11-04
RESCUE: PCSK9 Inhibitors for Carotid Vulnerable Plaque Remodeling
Intervention 1, Intervention 3, Intervention 2 - Atherosclerosis Cerebral, Carotid Plaque
Phase 4Not yet recruitingKeqiang Zhao1202027-01-012026-09-15
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
Atogepant 60 mg, Placebo - Migraine Disorders, Brain, Healthy Adult Participants
Phase 4Not yet recruitingKonrad Peter Weber802027-01-012026-09-17
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
Phase 4Not yet recruitingElizabeth Donner252027-01-012026-09-11
Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage
Normal Saline, Nicardipine - Subarachnoid Hemorrhage
Phase 4Not yet recruitingWake Forest University Health Sciences2142027-01-012026-10-01
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
Rivaroxaban 2.5 Mg Oral Tablet, Colchicine 0.5 MG, Placebo Rivaroxaban - Ischemic Stroke
Phase 4Not yet recruitingBrazilian Clinical Research Institute45002027-01-012026-10-30
Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms
Methylprednisolone (Injectable Form), Placebo Injection - Unruptured Intracranial Aneurysms, Cerebrovascular Event
Phase 4Not yet recruitingDuan Chuanzhi8642026-11-302026-10-26
A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS
Cannabidiol Oral Solution - Lennox-Gastaut Syndrome
Phase 4Not yet recruitingJazz Pharmaceuticals402026-11-182026-10-22
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease
Phase 4Not yet recruitingVA Office of Research and Development1462026-11-092026-10-27
Lumbrokinase vs Placebo in Moderate-to-Severe Ischemic Stroke
Lumbrokinase, Lumbrokinase Placebo - Ischemic Stroke, Acute
Phase 4Not yet recruitingXinqiao Hospital of Chongqing11962026-11-012026-08-13
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease
Donanemab - Alzheimer Disease
Phase 4Not yet recruitingEli Lilly and Company502026-11-012026-10-15
Propofol Target-Controlled Infusion Versus Dexmedetomidine for Sedation During Chronic Subdural Hematoma Surgery Under Local Anesthesia
Dexmedetomidine, Propofol (Astra-Zeneca) - Chronic Subdural Hematoma
Phase 4Not yet recruitingNational Institute of Neurology, Tunisia602026-11-012026-11-03
Effectiveness and Tolerability of a Treat-to-Target Versus Fixed-Dose Statin Strategy in Patients With Atherosclerotic Cardiovascular Disease
Dose adjustment of statins, no dose adjustment - Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia, Stroke (CVA) or TIA
Phase 4Not yet recruitingRehman Medical Institute - RMI1782026-11-012026-11-05
Oral Anticoagulation in Patients With Prior Deep Intracerebral Hemorrhage, Atrial Fibrillation, and Ischemic Stroke
Apixaban, No Oral Anticoagulation Strategy - Intracerebral Hemorrhage, Atrial Fibrillation (AF)
Phase 4Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine8522026-10-262026-10-20
Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment
Metoclopramide 10mg, Acetaminophen - Concussion Post Syndrome, Head Trauma Injury
Phase 4Not yet recruitingMontefiore Medical Center2002026-10-012026-10-01
Anti-inflammatory Effect of MgSO₄ in Patients With Moderate Traumatic Brain Injury by Measurming Nucleotide-binding Oligomerization Domain-Like Receptor Pyrin Domain-containing 3 (NLRP3) Inflammasome-a Multiprotein Complex
Magnesium sulfate (MgSO4), Normal Saline - Traumatic Brain Injuries
Phase 4Not yet recruitingAssiut University642026-10-012026-08-13
Tirofiban Combined With Aspirin in Moderate Ischemic Stroke
Tirofiban, Tirofiban-matching placebo - Ischemic Stroke, Acute
Phase 4Not yet recruitingXinqiao Hospital of Chongqing11682026-10-012026-08-12

Showing 20 of 1622. Sign in to see all of them.

Narrower conditions

Stroke (232)  ·  Parkinson Disease (172)  ·  Migraine Disorders (159)  ·  Ischemic Stroke (149)  ·  Alzheimer Disease (137)  ·  Epilepsy (117)  ·  Dementia (73)  ·  Brain Injuries, Traumatic (60)  ·  Cognitive Dysfunction (46)  ·  Headache (42)  ·  Seizures (39)  ·  Atrial Fibrillation (38)  ·  Hepatic Encephalopathy (35)  ·  Brain Neoplasms (34)  ·  Brain Injuries (32)

Broader conditions

Central Nervous System Diseases (1617)  ·  Nervous System Diseases (1612)  ·  Vascular Diseases (551)  ·  Cardiovascular Diseases (544)  ·  Cerebrovascular Disorders (522)  ·  Pathological Conditions, Signs and Symptoms (476)  ·  Neurodegenerative Diseases (350)  ·  Mental Disorders (288)  ·  Signs and Symptoms (252)  ·  Pathologic Processes (249)  ·  Neurologic Manifestations (224)  ·  Neurocognitive Disorders (222)  ·  Basal Ganglia Diseases (201)  ·  Movement Disorders (200)

Interventions

Aspirin (58)  ·  Clopidogrel (44)  ·  Saline Solution (40)  ·  Sodium Chloride (37)  ·  Donepezil (36)  ·  Levetiracetam (36)  ·  Memantine (34)  ·  Botulinum Toxins, Type A (30)  ·  Topiramate (30)  ·  Atorvastatin (29)  ·  Dexmedetomidine (27)  ·  Propofol (23)  ·  erenumab (21)  ·  Cilostazol (20)  ·  Methylphenidate (18)

Sponsors

Pfizer (25)  ·  Genzyme, a Sanofi Company (22)  ·  Novartis Pharmaceuticals (18)  ·  Novartis (17)  ·  Beijing Tiantan Hospital (15)  ·  Seoul National University Hospital (14)  ·  Mayo Clinic (13)  ·  GlaxoSmithKline (12)  ·  Montefiore Medical Center (12)  ·  VA Office of Research and Development (12)  ·  Eisai Korea Inc. (11)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (11)  ·  UCB Pharma (11)  ·  Amgen (10)  ·  Asan Medical Center (10)

Countries

United States (548)  ·  China (215)  ·  South Korea (99)  ·  Germany (95)  ·  France (94)  ·  Canada (83)  ·  Spain (81)  ·  Italy (76)  ·  United Kingdom (74)  ·  Denmark (44)  ·  Netherlands (40)  ·  Poland (37)  ·  Austria (35)  ·  India (34)  ·  Australia (33)

Top investigators

Roger K Cady, MD (10)  ·  Jihee Mun (6)

Results publications

PMID 33189083, PMID 25771069, PMID 37467180, PMID 12221155, PMID 16731270, PMID 24957314, PMID 29030456, PMID 34515113, PMID 35833913, PMID 37303034, PMID 38018702, PMID 11914403, PMID 12807523, PMID 15613435, PMID 15827109, PMID 18757238, PMID 21592984, PMID 21869730, PMID 22230384, PMID 22880024, PMID 22897803, PMID 23567060, PMID 27513651, PMID 27834686, PMID 28304224, PMID 28527771, PMID 28545923, PMID 28573499, PMID 30571333, PMID 31020900, PMID 32905623, PMID 34022170, PMID 34061144, PMID 36398903, PMID 36413436, PMID 36446950, PMID 36700520, PMID 37870112, PMID 39498781, PMID 40275185, PMID 41616808, PMID 8984084, PMID 10208286, PMID 10469005, PMID 10511011, PMID 10588403, PMID 10634801, PMID 10639539, PMID 10690849, PMID 10753982

NIH funding

2018 (12), 2009 (9), 2014 (9), 2019 (8), 2025 (8), 2008 (7), 2005 (6), 2015 (6), 2017 (5), 2023 (3), 5UL1TR001420-03 (2), K23MH067710 (2), 1RC3NS070646-01 (1), 2004 (1), 2016 (1)